358 related articles for article (PubMed ID: 18939514)
21. Expression of VEGF-C/-D and lymphangiogenesis in salivary adenoid cystic carcinoma.
Stárek I; Salzman R; Kučerová L; Skálová A; Hauer L
Pathol Res Pract; 2015 Oct; 211(10):759-65. PubMed ID: 26296919
[TBL] [Abstract][Full Text] [Related]
22. Potential implication of IL-24 in lymphangiogenesis of human breast cancer.
Frewer NC; Ye L; Sun PH; Owen S; Ji K; Frewer KA; Hargest R; Jiang WG
Int J Mol Med; 2013 May; 31(5):1097-104. PubMed ID: 23546515
[TBL] [Abstract][Full Text] [Related]
23. [The relationship between lymphangiogenesis and lymphatic metastasis in murine hepatic carcinoma of high and low metastatic potentialities].
Wang KF; Ye SL; Song LJ; Weng YQ; Liang CM; Zhao Y; Gao DM; Tang ZY
Zhonghua Gan Zang Bing Za Zhi; 2006 Mar; 14(3):187-91. PubMed ID: 16556412
[TBL] [Abstract][Full Text] [Related]
24. VEGFR signaling during lymphatic vascular development: From progenitor cells to functional vessels.
Secker GA; Harvey NL
Dev Dyn; 2015 Mar; 244(3):323-31. PubMed ID: 25399804
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of vascular endothelial growth factors A, C and D as indicators of lymphangiogenesis and angiogenesis in invasive and non-invasive urothelial carcinoma bladder.
Khadim MT; Ahmed SA; Khan FA; Ikram A; Shaikh SY
J Pak Med Assoc; 2015 Aug; 65(8):851-6. PubMed ID: 26228330
[TBL] [Abstract][Full Text] [Related]
26. Prognostic significance of vascular endothelial cell growth factors -A, -C and -D in breast cancer and their relationship with angio- and lymphangiogenesis.
Mohammed RA; Green A; El-Shikh S; Paish EC; Ellis IO; Martin SG
Br J Cancer; 2007 Apr; 96(7):1092-100. PubMed ID: 17353919
[TBL] [Abstract][Full Text] [Related]
27. Lymphangiogenesis, inflammation and metastasis.
Schoppmann SF
Anticancer Res; 2005; 25(6C):4503-11. PubMed ID: 16334134
[TBL] [Abstract][Full Text] [Related]
28. Pathogenesis of persistent lymphatic vessel hyperplasia in chronic airway inflammation.
Baluk P; Tammela T; Ator E; Lyubynska N; Achen MG; Hicklin DJ; Jeltsch M; Petrova TV; Pytowski B; Stacker SA; Ylä-Herttuala S; Jackson DG; Alitalo K; McDonald DM
J Clin Invest; 2005 Feb; 115(2):247-57. PubMed ID: 15668734
[TBL] [Abstract][Full Text] [Related]
29. Lymphatic vessels assessment in feline mammary tumours.
Sarli G; Sassi F; Brunetti B; Rizzo A; Diracca L; Benazzi C
BMC Cancer; 2007 Jan; 7():7. PubMed ID: 17222331
[TBL] [Abstract][Full Text] [Related]
30. Molecular and cellular mechanisms of lymphangiogenesis.
Al-Rawi MA; Mansel RE; Jiang WG
Eur J Surg Oncol; 2005 Mar; 31(2):117-21. PubMed ID: 15698725
[TBL] [Abstract][Full Text] [Related]
31. Role of VEGF-C and VEGF-D in lymphangiogenesis in gastric cancer.
Yonemura Y; Endo Y; Tabata K; Kawamura T; Yun HY; Bandou E; Sasaki T; Miura M
Int J Clin Oncol; 2005 Oct; 10(5):318-27. PubMed ID: 16247658
[TBL] [Abstract][Full Text] [Related]
32. The tyrosine kinase inhibitor cediranib blocks ligand-induced vascular endothelial growth factor receptor-3 activity and lymphangiogenesis.
Heckman CA; Holopainen T; Wirzenius M; Keskitalo S; Jeltsch M; Ylä-Herttuala S; Wedge SR; Jürgensmeier JM; Alitalo K
Cancer Res; 2008 Jun; 68(12):4754-62. PubMed ID: 18559522
[TBL] [Abstract][Full Text] [Related]
33. Why and how do tumors stimulate lymphangiogenesis?
Cao Y
Lymphat Res Biol; 2008; 6(3-4):145-8. PubMed ID: 19093786
[TBL] [Abstract][Full Text] [Related]
34. [Advances in lymphangiogenesis and metastasis of tumor].
Yan XC; Yu DM; Liu FX
Zhonghua Bing Li Xue Za Zhi; 2005 Jun; 34(6):370-2. PubMed ID: 16185511
[No Abstract] [Full Text] [Related]
35. [Morphogenesis, structure and properties of lymphatic vessels].
Ratajska A; Jankowska-Steifer E; Czarnowska E; Flaht A; Radomska-Leśniewska D
Postepy Hig Med Dosw (Online); 2012 Nov; 66():901-12. PubMed ID: 23175346
[TBL] [Abstract][Full Text] [Related]
36. Lymphangiogenesis in aortic valve stenosis--novel regulatory roles for valvular myofibroblasts and mast cells.
Syväranta S; Helske S; Lappalainen J; Kupari M; Kovanen PT
Atherosclerosis; 2012 Apr; 221(2):366-74. PubMed ID: 22281299
[TBL] [Abstract][Full Text] [Related]
37. IGFBP7 functions as a potential lymphangiogenesis inducer in non-small cell lung carcinoma.
Zhao W; Wang J; Zhu B; Duan Y; Chen F; Nian W; Sun J; Zhang B; Tong Z; Chen Z
Oncol Rep; 2016 Mar; 35(3):1483-92. PubMed ID: 26706909
[TBL] [Abstract][Full Text] [Related]
38. Intratumoral c-Met expression is associated with vascular endothelial growth factor C expression, lymphangiogenesis, and lymph node metastasis in oral squamous cell carcinoma: implications for use as a prognostic marker.
Zhao D; Wang SH; Feng Y; Hua CG; Zhao J; Tang XF
Hum Pathol; 2011 Oct; 42(10):1514-23. PubMed ID: 21531000
[TBL] [Abstract][Full Text] [Related]
39. Lymphangiogenesis and angiogenesis in bladder cancer: prognostic implications and regulation by vascular endothelial growth factors-A, -C, and -D.
Miyata Y; Kanda S; Ohba K; Nomata K; Hayashida Y; Eguchi J; Hayashi T; Kanetake H
Clin Cancer Res; 2006 Feb; 12(3 Pt 1):800-6. PubMed ID: 16467091
[TBL] [Abstract][Full Text] [Related]
40. [Characterization of markers and growth factors for lymphatic endothelium].
Waś H
Postepy Biochem; 2005; 51(2):209-14. PubMed ID: 16209358
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
